- Home
- BEKE vs WST Comparison
BEKE vs WST Comparison
Compare BEKE & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEKE
- WST
- Stock Information
- Founded
- BEKE 2001
- WST 1923
- Country
- BEKE China
- WST United States
- Employees
- BEKE N/A
- WST N/A
- Industry
- BEKE Real Estate
- WST Medical/Dental Instruments
- Sector
- BEKE Finance
- WST Health Care
- Exchange
- BEKE Nasdaq
- WST Nasdaq
- Market Cap
- BEKE 22.4B
- WST 18.9B
- IPO Year
- BEKE 2020
- WST N/A
- Fundamental
- Price
- BEKE $19.90
- WST $254.64
- Analyst Decision
- BEKE Strong Buy
- WST Strong Buy
- Analyst Count
- BEKE 6
- WST 8
- Target Price
- BEKE $24.97
- WST $329.43
- AVG Volume (30 Days)
- BEKE 6.2M
- WST 552.4K
- Earning Date
- BEKE 08-26-2025
- WST 10-23-2025
- Dividend Yield
- BEKE 1.83%
- WST 0.35%
- EPS Growth
- BEKE N/A
- WST N/A
- EPS
- BEKE 0.46
- WST 6.68
- Revenue
- BEKE $14,384,647,393.00
- WST $2,960,200,000.00
- Revenue This Year
- BEKE $16.76
- WST $6.28
- Revenue Next Year
- BEKE $12.40
- WST $6.02
- P/E Ratio
- BEKE $43.58
- WST $37.92
- Revenue Growth
- BEKE 32.52
- WST 2.90
- 52 Week Low
- BEKE $13.30
- WST $187.43
- 52 Week High
- BEKE $26.05
- WST $352.33
- Technical
- Relative Strength Index (RSI)
- BEKE 63.78
- WST 56.24
- Support Level
- BEKE $19.57
- WST $253.38
- Resistance Level
- BEKE $20.33
- WST $264.06
- Average True Range (ATR)
- BEKE 0.42
- WST 5.43
- MACD
- BEKE 0.16
- WST 0.36
- Stochastic Oscillator
- BEKE 85.07
- WST 57.96
About BEKE KE Holdings Inc (each representing three)
KE Holdings, or Beike, is a large residential real estate sales and rental brokerage company in China. Founded in 2001, the company operates through self-owned Lianjia stores in Beijing and Shanghai and connected third-party agencies, including franchise brand Deyou in other cities, with commissions charged on existing-home and new-home transactions. Leveraging an online-offline hybrid model, Beike also attract clients through its namesake online marketplace. The company tapped into home renovation services by acquiring Shengdu Home Decoration in 2022. As of the end of 2024, Beike's co-founders collectively control the company, while Tencent and its affiliates share 8% of voting power.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.